drugset / Trial / NCT00163566

Study of DHT-Gel to Treat the Symptoms of Low Testosterone in Men 55-80

NCT00163566 ↗

Phase 2 Completed 128 enrolled ASCEND Therapeutics
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to evaluate whether DHT-Gel, when applied daily to the skin, can relieve the symptoms of low testosterone in men aged 55-80. These symptoms include reduced muscle strength, increase fat mass, low libido, feeling blue or moody

Timeline

Start
2004-10
Primary completion
2006-09
Completion
2006-09-25

Drugs

EvaluationDrugModalityDoseRoute
Comparator STANOLONE Small molecule 35 mg Other
Comparator STANOLONE Small molecule 70 mg Other

Indications